Hanmi Science Co., Ltd.

A008930

KR7008930000

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
33,500 ^KRW	+0.60%		+4.69%	-14.54%

Apr. 08	Hanmi Science Co., Ltd. cancelled the transaction announced on January 12, 2024	CI
Mar. 28	OCI Holdings Company Ltd. cancelled the acquisition of 10.94% stake in Hanmi Science Co., Ltd. from Song Young Sook, Kim Won Se and Kim JI Woo.	CI

Tranche Update on Hanmi Science Co., Ltd.'s Equity Buyback Plan announced on October 24, 2023.

January 26, 2024 at 01:52 am EST

From October 24, 2023 to December 31, 2023, the company has repurchased 49,957 shares, representing 0.07% for KRW 1,929.9 million. With this, the company has completed the repurchase of 49,957 shares, representing 0.07% for KRW 1,929.9 million under the buyback announced on October 24, 2023.

Latest news about Hanmi Science Co., Ltd.

Hanmi Science Co., Ltd. cancelled the transaction announced on January 12, 2024	Apr. 07	CI
OCI Holdings Company Ltd. cancelled the acquisition of 10.94% stake in Hanmi Science Co., Ltd. from Song Young Sook, Kim Won Se and Kim JI Woo.	Mar. 27	CI
Hanmi Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 20	CI
Tranche Update on Hanmi Science Co., Ltd.'s Equity Buyback Plan announced on October 24, 2023.	Jan. 26	CI
Tranche Update on Hanmi Science Co., Ltd.'s Equity Buyback Plan announced on October 24, 2023.	Jan. 26	CI
Hanmi Science Co., Ltd.'s Equity Buyback announced on October 24, 2023, has expired with 268,859 shares, representing 0.4% for KRW 9,341.62 million.	Jan. 23	CI
OCI Holdings Company Ltd. signed an agreement to acquire 10.94% stake in Hanmi Science Co., Ltd. from Song Young Sook, Kim Won Se and Kim JI Woo.	Jan. 11	CI
Hanmi Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Hanmi Science's Net Income Doubles in Q3	Nov. 02	MT
Hanmi Science Co., Ltd. announces an Equity Buyback for 330,000 shares.	23-10-24	CI
Hanmi Science Co., Ltd. authorizes a Buyback Plan.	23-10-23	CI
Hanmi Science Co., Ltd. Announces Successful Launch of JVM's Automated Drug Dispensing System via High-End Robot Arm 'MENITH' in the European Market	23-10-16	CI
Hanmi Science's Net Income Jumps 70.2% in Q2	23-08-01	MT
Hanmi Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Hanmi Science's Net Income Jumps 60% in Q1; Shares Decline 3%	23-04-26	MT
South Korean Stocks Decline on Uncertainty over US Fed Rate Hike; NCSoft Loses 6%	23-02-09	MT
Hanmi Science's Net Income Jumps 107% in Q4	23-02-09	MT
Hanmi Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Hanmi Science's Net Profit Falls 4.8% in Q3	22-11-01	MT
Hanmi Science Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Hanmi Science's Net Income Jumps 36% in Q2; Shares Rise 3%	22-07-26	MT
Hanmi Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Hanmi Science's Net Income Jumps 45% in Q1	22-04-28	MT
Hanmi Science Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-08	CI
Hanmi Science Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI

Chart Hanmi Science Co., Ltd.

Duration

Period

More charts

Company Profile

Hanmi Science Co Ltd is a Korean-based holding company principally involved in the management of subsidiaries. Through subsidiaries in Japan, Europe and Korea, the Company operates in three segments. The Pharmaceutical Products Wholesale segment mainly engages in the distribution of pharmaceutical products. The Holding Business segment mainly engages in the business of controlling subsidiaries. The Other segment mainly engage in the production and sales of pharmaceuticals, and the supply of quasi-drugs and health functional foods, beverages and functional cosmetics.

Sector

Pharmaceuticals

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
HANMI SCIENCE CO., LTD.	-14.54%	1.65B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.77%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+11.35%	14.09B
CIPLA LIMITED	+12.08%	13.64B
ZYDUS LIFESCIENCES LIMITED	+39.52%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B